Legend Biotech Corp. (LEGN)
20.94
-0.88
(-4.03%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
+0.37
(+1.77%)
After-Hours: 20:00
Legend Biotech Net Income (Quarterly) : 33.25M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.25M |
| March 31, 2026 | -54.46M |
| December 31, 2025 | -30.95M |
| September 30, 2025 | -39.74M |
| June 30, 2025 | -125.83M |
| March 31, 2025 | -100.92M |
| December 31, 2024 | 26.19M |
| September 30, 2024 | -125.32M |
| June 30, 2024 | -18.20M |
| March 31, 2024 | -59.79M |
| December 31, 2023 | -144.82M |
| September 30, 2023 | -62.21M |
| June 30, 2023 | -199.13M |
| March 31, 2023 | -112.10M |
| Date | Value |
|---|---|
| December 31, 2022 | -135.88M |
| September 30, 2022 | -84.96M |
| June 30, 2022 | -193.23M |
| March 31, 2022 | -32.29M |
| December 31, 2021 | -88.33M |
| September 30, 2021 | -125.39M |
| June 30, 2021 | -91.58M |
| March 31, 2021 | -90.35M |
| December 31, 2020 | -58.00M |
| September 30, 2020 | -66.55M |
| June 30, 2020 | -134.88M |
| March 31, 2020 | -44.23M |
| December 31, 2019 | -63.94M |
| September 30, 2019 | -27.80M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AbbVie, Inc. | 3.604B |
| Dianthus Therapeutics, Inc. | -50.22M |
| Gilead Sciences, Inc. | -10.50B |
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Arbutus Biopharma Corp. | -5.143M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 388.14M |
| Total Expenses (Quarterly) | 354.89M |
| EPS Diluted (Quarterly) | 0.1716 |
| Enterprise Value | 3.371B |
| Gross Profit Margin (Quarterly) | 61.52% |
| Profit Margin (Quarterly) | 8.57% |
| Earnings Yield | -2.41% |
| Normalized Earnings Yield | -2.355 |